In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway

Progress in Neurobiology

Volumn 58, Issue 1, 1999, Pages 89-120

  Fedele, Ernesto ^a   Raiteri, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; CYCLIC GMP; DIZOCILPINE; GLUTAMATE RECEPTOR; NICOTINE; [3 (3,4 DICHLOROBENZYLAMINO)PROPYL](DIETHOXYMETHYL)PHOSPHINIC ACID;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; EPILEPSY; GABAERGIC TRANSMISSION; LEARNING; MEMORY; MICRODIALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0032954744     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00077-X     Document Type: Review

References (168)

1. Alagarsamy S., Lonart G., Johnson K. M. The role of P-type calcium channels in the depolarisation-induced activation of nitric oxide synthase in frontal cortex. J. Neurochem. 62:1994;400-403.
2. Albuquerque E. X., Alkondon M., Pereira E. F. R., Castro N. G., Schrattenholz A., Barbosa C. T. F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H. M., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. exp. Ther. 280:1997;1117-1136.
3. Andreasen M., Lambert J. D. C., Skovgaard Jensen M. Effects of new non-N-methyl-D-aspartate antagonists on synaptic transmission in the in vitro rat hippocampus. J. Physiol. 414:1988;317-336.
4. Aram J. A., Martin D., Tomczyk M., Zeman S., Millar J., Pohler G., Lodge D. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J. Pharmacol. exp. Ther. 248:1989;320-328.
5. Ariano M. A., Lewicki J. A., Brandwein J. H., Murad F. Immunohistochemical localization of guanylate cyclase within neurons of rat brain. Proc. natl Acad. Sci. USA. 79:1982;1316-1320.
6. Audinat E., Gahwiler H. G., Knopfel T. Excitatory synaptic potentials in neurons of the deep nuclei in olivo-cerebellar slice cultures. Neuroscience. 49:1992;903-911.
7. Bagetta G., Iannone M., Lombardi U., Nisticò G. Role of nitric oxide in the pathophysiology of epileptogenic discharges in rats. Pharmacol. Commun. 2:1993;261-270.
8. 3H]-L-glutamate release from rat hippocampal synaptosomes. Br. J. Pharmacol. 113:1994;339-341.
9. Bartfai T., Langel U., Bedecs K., Andell S., Land T., Gregersen S., Ahren B., Girotti P., Consolo S., Corwin R., Crawley J., Xu X., Wiesenfeld Hallin Z., Hökfelt T. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc. natl Acad. Sci. USA. 90:1993;11287-11291.
10. Boulton C. L., Southam E., Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 69:1995;699-703.
11. Boxall A. R., Garthwaite J. Long-term depression in rat cerebellum requires both NO synthase and NO-sensitive guanylyl cyclase. Eur. J. Neurosci. 8:1996;2209-2212.
12. B receptor site distribution in the rat central nervous system. Neuroscience. 20:1987;365-383.
13. Bredt D. S., Snyder S. H. Nitric oxide mediated glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. natl Acad. Sci. USA. 86:1989;9030-9033.
14. Bredt D. S., Snyder S. H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. natl Acad. Sci. USA. 87:1990;682-685.
15. Bredt D. S., Hwang P. M., Snyder S. H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
16. Bredt D. S., Glatt C., Hwang P., Fotuhi M., Dawson T., Snyder S. H. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron. 7:1991;615-624.
17. Breer H., Shepherd G. M. Implications of the NO/cGMP system for olfaction. Trends Neurosci. 16:1993;5-9.
18. Brioni J. D., Arneric S. P. Nicotinic receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms. Behav. Neural Biol. 59:1993;57-62.
19. Buccafusco J. J., Jackson W. J., Terry A. V. Jr., Marsh K. C., Decker M. W., Arneric S. P. Improvement in performance of a delayed matching-to-sample task by monkeys following a novel cholinergic channel activator for memory enhancement. Psychopharmacology. 120:1995;256-266.
20. Burgunder J. M., Cheung P. T. Expression of soluble guanylyl cyclase gene in adult rat brain. Eur. J. Pharmac. 6:1994;211-217.
21. Chan-Palay, V. (1982) In: The Cerebellum - New Vistas, pp. 552-585. Eds. S. L. Palay and V. Chan Palay. Springer Verlag, Berlin.
22. B binding sites in rat central nervous system: a quantitative autoradiographical study. Neuroscience. 34:1990;341-357.
23. 3H]-CGP 39653 mapping of glutamatergic N-methyl-D-aspartate receptors in the brain of aged rats. Neurosci. Res. Commun. 12:1993;31-39.
24. 3H]dopamine release. Br. J. Pharmac. 117:1996;595-606.
25. Collingridge, G. L. and Singer, W. (1991) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmac. Sci. Spec. Rep. 42-47.
26. Collingridge G. L., Herron C. E., Lester R. A. Frequency-dependent N-methyl-D-aspartate receptor-mediated synaptic transmission in rat hippocampus. J. Physiol. 399:1988;301-312.
27. Consolo S., Baldi G., Russi G., Civenni G., Bartfai T., Vezzani A. Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc. natl Acad. Sci. USA. 91:1994;8047-8051.
28. Consolo S., Uboldi M. C., Caltavuturo C., Bartfai T. Galanin stimulates the N-methyl-D-aspartate receptor nitric oxide cyclic GMP pathway in vivo in the rat ventral hippocampus. Neuroscience. 85:1998;819-826.
29. Crepel F., Jaillard D. Protein kinases, nitric oxide and long-term depression of synapses in the cerebellum. Neuroreport. 1:1990;133-136.
30. Daniel H., Hemart N., Jaillard D., Crepel F. Long-term depression requires nitric oxide and guanosine 3′,5′ cyclic monophosphate production in rat cerebellar Purkinje cells. Eur. J. Neurosci. 5:1993;1079-1082.
31. Dawson D. A. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc. Brain Metab. Rev. 6:1994;299-324.
32. De Camilli P., Miller P. E., Levitt P., Walter U., Greengard P. Anatomy of cerebellar Purkinje cells in the rat determined by a specific immunohistochemical marker. Neuroscience. 11:1984;761-817.
33. Decker M. W., Majchrzak M. J., Arneric S. P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45:1993;571-576.
34. De Sarro G., Donato Di Paola E., De Sarro A., Vidal M. J. L-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur. J. Pharmac. 230:1993;151-158.
35. Desce J. M., Godeheu G., Galli T., Artaud F., Chéramy A., Glowinski J. L-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience. 47:1992;333-339.
36. Dinerman J. L., Dawson T. M., Schell M. J., Snowman A., Snyder S. H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. natl Acad. Sci. USA. 91:1994;4214-4218.
37. Dingledine R., Hynes M. A., King G. L. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J. Physiol. (Lond.). 380:1986;175-189.
38. Drummond G. S., Kappas A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc. natl Acad. Sci. USA. 78:1981;6466-6470.
39. Dutar P., Lamour Y., Nicoll R. A. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur. J. Pharmac. 164:1989;355-360.
40. Endoh M., Maiese K., Wagner A. Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons. Neuroscience. 63:1994;679-689.
41. Fedele E., Raiteri M. Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: an in vivo cGMP microdialysis study in rat cerebellum. Br. J. Pharmac. 117:1996;1133-1138.
42. Fedele E., Jin Y., Varnier G., Raiteri M. in vivo microdialysis study of specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cGMP pathway. Br. J. Pharmac. 119:1996;590-594.
43. Fedele E., Bisaglia M., Raiteri M. D-Serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis. Naunyn-Schmiedeb. Arch. Pharmac. 355:1997;43-47.
44. Fedele E., Conti A., Raiteri M. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences. Neuropharmacology. 36:1997;1393-1403.
45. B receptors modulating the glutamate receptor/NO/cyclic GMP pathway in the rat hippocampus. Neuropharmacology. 36:1997;1405-1415.
46. Fedele, E., Varnier G., Ansaldo, M. A. and Raiteri, M. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br. J. Pharmac. 125, 1042-1048.
47. Fisone G., Wu C. F., Consolo S., Nordström O., Brynne N., Bartfai T., Melander T., Hökfelt T. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc. natl Acad. Sci. USA. 84:1987;7339-7343.
48. Fontana G., Fedele E., Cossu M., Munari C., Raiteri M. Activation of brain nitric oxide synthase in depolarized human temporal cortex slices: differential role of voltage-sensitive calcium channels. Br. J. Pharmac. 122:1997;930-934.
49. Friedl A., Harmening Ch., Schmalz F., Schuricht B., Schiller M., Hamprecht B. Elevation by atrial natriuretic factors of cyclic GMP levels in astroglia-rich cultures from murine brain. J. Neurochem. 52:1989;589-597.
50. Gabriel S. M., Rivkin A., Mercado J. Jr. The galanin antagonist, M-15, inhibits growth hormone release in rats. Peptides. 14:1993;633-636.
51. Garthwaite J., Brodbelt A. R. Glutamate as the principal mossy fibre transmitter in rat cerebellum: pharmacological evidence. Eur. J. Neurosci. 2:1989;177-180.
52. Garthwaite J., Charles S. L., Chess-Williams R. Endothelium derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
53. Garthwaite J., Garthwaite G., Palmer R. M. J., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmac. 172:1989;413-416.
54. Garthwaite J., Southam E., Boulton C. L., Nielsen E. B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmac. 48:1995;184-188.
55. Gibson T. R., Wildey G. M., Manaker S., Glembotski C. G. Autoradiographic localization and characterization of atrial natriuretic peptide binding sites in the rat central nervous system and adrenal gland. J. Neurosci. 6:1986;2004-2011.
56. Globus M. Y., Prado R., Busto R. Ischemia-induced changes in extracellular levels of striatal cyclic GMP: role of nitric oxide. Neuroreport. 6:1995;1909-1912.
57. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59:1992;848-856.
58. Gray R., Rajan A. S., Radcliffe K. A., Yakehiro M., Dani J. A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
59. Greenberg L. H., Troyer E., Ferrendelli J. A., Weiss B. Enzymatic regulation of the concentration of cyclic GMP in mouse brain. Neuropharmacology. 17:1978;737-745.
60. Gustafsson B., Wigström H., Abraham W. C., Huang Y. Y. Long-term potentiation in the hippocampus using depolarizing current pulse as the conditioning stimulus to single volley synaptic potentials. J. Neurosci. 7:1987;774-780.
61. Hawkins R. D., Kandel E. R., Siegelbaum S. A. Learning to modulate transmitter release: themes and variations in synaptic plasticity. A. Rev. Neurosci. 16:1993;625-665.
62. Herron C. E., Williamson R., Collingridge G. L. A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci. Lett. 61:1985;255-260.
63. Hoffer B. J., Siggins G. R., Oliver A. P., Bloom F. E. Cyclic AMP mediation of norepinephrine synaptic inhibition in rat cerebellar cortex: a unique class of synaptic responses. Ann. N.Y. Acad. Sci. 185:1971;531-549.
64. Hoffer B., Seiger A., Freedman R., Olson L., Taylor D. Electrophysiology and cytology of hippocampal formation transplants in the anterior chamber of the eye II. Cholinergic mechanisms. Brain Res. 119:1977;107-132.
65. Hollmann M., Heinemann S. Cloned glutamate receptors. A. Rev. Neurosci. 17:1994;31-108.
66. 2+ in cultured neurons from rat brain. J. Neurochem. 64:1995;2049-2056.
67. Hussain S., Gardner C. R., Bagust J., Walker R. J. Receptor subtypes involved in responses of Purkinje cell to exogenous excitatory amino acids and local electrical stimulation in cerebellar slices in the rat. Neuropharmacology. 30:1991;1029-1037.
68. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
69. Ignarro L. J., Ballot B., Wood K. S. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J. Biol. Chem. 259:1984;6201-6207.
70. Ito M. Long-term depression. A. Rev. Neurosci. 12:1989;85-102.
71. Johnson J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531.
72. Kendrick K. M., Guevara-Guzman R., Zorrilla J., Hinton M. R., Broad K. D., Mimmack M., Ohkura S. Formation of olfactory memories mediated by nitric oxide. Nature. 388:1997;670-674.
73. Kito S., Miyoshi R., Nomoto T. Influence of age on NMDA receptor complex in rat brain studied by in vitro autoradiography. J. Histochem. Cytochem. 38:1990;1725-1731.
74. Kleckner N. W., Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. 241:1988;835-837.
75. Lacaille, J.-C., Dunkel, D. D. and Schwartzkroin, P. A. (1989) Electrophysiological and morphological characterization of hippocampal interneurons. In: The Hippocampus - New Vistas, pp. 287-305. Eds. V. Chan-Palay and C. Köhler. Alan R. Liss, New York.
76. Laitinen J. T., Laitinen K. S. M., Tuomisto L., Airaksinen M. M. Differential regulation of cyclic GMP levels in the frontal cortex and the cerebellum of anesthetized rats by nitric oxide: an in vivo microdialysis study. Brain Res. 668:1994;117-121.
77. Laitinen K. S., Salovaara K., Severgnini S., Laitinen J. T. Regulation of cyclic GMP levels in the rat frontal cortex in vivo: effects of exogenous carbon monoxide and phosphodiesterase inhibition. Brain Res. 755:1997;272-278.
78. LaMarre Y., de Montigny C., Dumont M., Weiss M. Harmaline-induced rhythmic activity of cerebellar and lower brainstem neurons. Brain Res. 32:1971;246-250.
79. A receptor-mediated chloride current in cultured rat hippocampal neurons via an extracellular site. J. Pharmac. exp. Ther. 255:1990;90-94.
80. Lawrence A. D., Sahakian B. J. Alzheimer disease, attention, and the cholinergic system. Alzheimer Dis. Assoc. Disord. 9:1995;43-49.
81. Leigh P. N., Connick J. H., Stone T. W. Distribution of NADPH-diaphorase positive cells in the rat brain. Comp. Biochem. Physiol. 97C:1990;259-264.
82. Levin E. D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
83. Linden D. J., Dawson T. M., Dawson V. L. An evaluation of the nitric oxide/cGMP/cGMP-dependent protein kinase cascade in the induction of cerebellar long-term depression in culture. J. Neurosci. 15:1995;5098-5105.
84. Lindskog S., Ahren B., Land T., Langel U., Bartfai T. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur. J. Pharmac. 210:1992;183-188.
85. Llinas R., Muhlethaler M. Electrophysiology of guinea-pig cerebellar nuclear cells in the in vitro brain stem-cerebellar preparation. J. Physiol. (Lond.). 404:1988;241-258.
86. Llinas R., Volkind R. A. The olivo-cerebellar system: functional properties as revealed by harmaline-induced tremor. Exp. Brain Res. 18:1973;69-87.
87. Lohmann S. M., Walter U., Miller P. E., Greengard P., De Camilli P. Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc. natl Acad. Sci. USA. 78:1981;653-657.
88. Luo D., Vincent S. R. Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo. Eur. J. Pharmac. 267:1994;263-267.
89. Luo D., Knezevich S., Vincent S. R. N-Methyl-D-aspartate-induced nitric oxide release: an in vivo microdialysis study. Neuroscience. 57:1993;897-900.
90. Luo D., Leung E., Vincent S. R. Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex. J. Neurosci. 14:1994;263-271.
91. Magnusson K. R. Differential effects of aging on binding sites of the activated NMDA receptor complex in mice. Mech. Ageing Dev. 84:1995;227-243.
92. Mao C. C., Guidotti A., Costa E. The regulation of cyclic guanosine monophosphate in rat cerebellum: possible involvement of putative amino acid neurotransmitters. Brain Res. 79:1974;510-514.
93. Marchi M., Raiteri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function. J. Neurochem. 67:1996;1974-1981.
94. Marin P., Quignard J. F., Lafon-Cazal M., Bockaert J. Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons. Neuropharmacology. 32:1993;29-36.
95. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349:1991;760-765.
96. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G., Hanoune J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12:1992;3350-3360.
97. McCaslin P. P., Morgan W. W. Continuously infused 2-amino-7-phosphonopentanoic acid antagonizes N-methyl-D-aspartate-induced elevations of cyclic GMP in vivo in multiple brain areas and chemically-induced seizure activity. Neuropharmacology. 25:1986;905-909.
98. McGehee D. S., Heath M. J. S., Gelber S., Devay P., Role R. W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
99. Miki N., Kawabe Y., Kuriyama K. Activation of cerebral guanylate cyclase by nitric oxide. Biochem. biophys. Res. Commun. 75:1977;851-856.
100. Miyoshi R., Kito S., Doudou N., Nomoto T. Age-related changes of strychnine-insensitive glycine receptors in rat brain as studied by in vitro autoradiography. Synapse. 6:1990;338-343.
101. Mollace V., Bagetta G., Nisticò G. Evidence that L-arginine possesses proconvulsant effects mediated through nitric oxide. Neuroreport. 2:1991;269-272.
102. Mollace V., Rodino P., Massoud R., Rotiroti D., Nisticò G. Age-dependent changes of NO synthase activity in the rat brain. Biochem. biophys. Res. Commun. 215:1995;822-827.
103. Morris R. G. M., Anderson E., Lynch G. S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by N-methyl-D-aspartate antagonist. Nature. 319:1986;774-776.
104. Nakane M., Ichikawa M., Deguchi T. Light and electron microscopic demonstration of guanylate cyclase in rat brain. Brain Res. 273:1983;9-15.
105. Nicoletti F., Wroblewski J. T., Novelli A., Alho H., Guidotti A., Costa E. The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J. Neurosci. 6:1986;1905-1911.
106. O'Dell T. J., Hawkins R. D., Kandel E., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. natl Acad. Sci. USA. 88:1991;11285-11289.
107. Okada D. Two pathways of cyclic GMP production through glutamate receptor-mediated nitric oxide synthesis. J. Neurochem. 59:1992;1203-1210.
108. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
109. Peterson C., Cotman C. W. Strain-dependent decrease in glutamate binding to the N-methyl-D-aspartic acid receptor during aging. Neurosci. Lett. 104:1989;309-313.
110. Phillis J. W., Kostopoulos G. K., Limacher J. J. Depression of corticospinal cells by various purines and pyrimidines. Can. J. Physiol. Pharmac. 52:1974;1226-1229.
111. Pin J. P., Joly C., Heinemann S. F., Bockaert J. Domains involved in the specificity of G protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO J. 13:1994;342-348.
112. Pittaluga A., Raiteri M. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur. J. Pharmac. 191:1990;231-234.
113. Pittaluga A., Fedele E., Risiglione C., Raiteri M. Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. Eur. J. Pharmac. 231:1993;129-134.
114. Pittaluga A., Bonfanti A., Raiteri M. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn-Schmiedeb. Arch. Pharmac. 356:1997;29-38.
115. 1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices. J. Pharmac. Exp. Ther. 257:1991;1184-1188.
116. Raiteri M., Garrone B., Pittaluga A. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. J. Pharmac. Exp. Ther. 260:1992;238-242.
117. Rosenberg P. A. Functional significance of cyclic AMP secretion in cerebral cortex. Brain Res. Bull. 29:1992;315-318.
118. Schlichter D. J., Detre J. A., Aswad D. W., Cherazi B., Greengard P. Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum. Proc. natl Acad. Sci. USA. 77:1980;5537-5541.
119. Schmidt M. J., Thornberry J. F. Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats. Brain Res. 139:1978;169-177.
120. Schmidt H. H., Gagne G. D., Nakane M., Pollock J. S., Miller M. F., Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH-diaphorase but not with soluble guanylyl cyclase and a novel paraneural function for nitrinergic signal transduction. J. Histochem. Cytochem. 90:1992;1439-1456.
121. Schuman, E. M. (1995) Nitric oxide signalling, long-term potentiation and long-term depression. In: Nitric Oxide in the Nervous System, pp. 125-150. Ed. S. Vincent. Academic Press, London.
122. Schuman E. M., Madison D. V. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science. 254:1991;1503-1506.
123. Scoville W. B., Milner B. Loss of recent memory after bilateral hippocampal lesions. J. Neurol. Neurosurg. Psychiat. 20:1957;11-21.
124. Seeburg P. H. The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:1993;359-365.
125. Shibuki K., Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature. 349:1991;326-328.
126. Siggins G. R., Henriksen S. J., Landis S. C. Electrophysiology of Purkinje neurons in the weaver mouse: iontophoresis of neurotransmitters and cyclic nucleotides, and stimulation of the nucleus locus coeruleus. Brain Res. 114:1976;53-69.
127. Sloviter R. S. Feedforward and feedback inhibition of hippocampal principal cell activity evoked by perforant path stimulation: GABA-mediated mechanisms that regulate excitability in vivo. Hippocampus. 1:1991;31-40.
128. Southam E., Garthwaite J. The nitric oxide-cyclic GMP signalling pathway in the rat brain. Neuropharmacology. 32:1993;1267-1277.
129. Southam E., East S. J., Garthwaite J. Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development. J. Neurochem. 56:1991;2072-2081.
130. Southam E., Morris R., Garthwaite J. Sources and targets of nitric oxide in rat cerebellum. Neurosci. Lett. 137:1992;241-244.
131. Squire L. R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99:1992;195-231.
132. Squire L. R., Davis H. P. The pharmacology of memory: a neurobiological perspective. A. Rev. Pharmac. Toxic. 21:1981;326-356.
133. Stone T. W., Taylor D. A., Bloom F. E. Cyclic AMP and cyclic GMP may mediate opposite neuronal responses in the rat cerebral cortex. Science. 187:1975;845-847.
134. Szatkowski M., Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 17:1994;359-365.
135. Tamaru M., Yoneda Y., Ogita K., Shimizu J., Nagata Y. Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res. 542:1991;83-90.
136. + or N-methyl-N′-nitro-N-nitrosoguanidine. Neurosci. Lett. 68:1986;95-99.
137. Tjornhammar M. L., Lazaridis G., Bartfai T. Cyclic GMP efflux from liver slices. J. Biol. Chem. 258:1983;6882-6886.
138. Toth E. Effect of nicotine on the level of extracellular amino acids in the hippocampus of rat. Neurochem. Res. 21:1996;903-907.
139. Vallebuona F., Raiteri M. Monitoring of cGMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity. Neuroscience. 57:1993;577-585.
140. Vallebuona F., Raiteri M. Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J. Neurosci. 14:1994;134-139.
141. Vallebuona F., Raiteri M. Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely-moving rats subjected to transcerebral microdialysis. Eur. J. Neurosci. 7:1995;694-701.
142. Valtschanoff J. G., Weinberg R. J., Kharazia V. N., Nakane H., Schmidt H. H. H. W. Neurons in rat hippocampus that synthesize nitric oxide. J. Comp. Neurol. 331:1993;111-121.
143. Van der Want J. J. L., Wiklund L., Guegan M., Ruigrok T., Voogd J. Anterograde tracing of the rat olivocerebellar system with Phaseolus vulgaris leucoagglutinin (PHA-L). Demonstration of climbing fiber collateral innervation of the cerebellar nuclei. J. Comp. Neurol. 288:1989;1-18.
144. de Vente J., Bol J. G. J. M., Hudson L., Schipper J., Steinbusch H. W. M. Atrial natriuretic factor-responding and cyclic guanosine monophosphate (cGMP)-producing cells in the rat hippocampus: a combined micropharmacological and immunocytochemical approach. Brain Res. 446:1988;387-395.
145. de Vente J., Manshanden C. G., Sikking R. A., Ramaekers F. C. S., Steinbusch H. W. M. A functional parameter to study heterogeneity of glial cells in rat brain slices: cyclic guanosine monophosphate production in atrial natriuretic factor (ANF)-responsive cells. Glia. 3:1990;43-54.
146. de Vente J., Bol J. G. J. M., Berkelmans H. S., Schipper J., Steinbusch H. M. W. Immunocytochemistry of cGMP in the cerebellum of the immature, adult, and aged rats: the involvement of nitric oxide. A micropharmacological study. Eur. J. Neurosci. 2:1990;845-862.
147. Verma A., Hirsch D. J., Glatt C. E., Ronnett G. V., Snyder S. H. Carbon monoxide: a putative neural messenger. Science. 259:1993;381-384.
148. Vincent S. R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
149. Warburton D. M. Nicotine as a cognitive enhancer. Progr. Neuropsychopharmac. Biol. Psychiat. 16:1992;181-191.
150. Wendland B., Schweizer F. E., Ryan T. A., Nakane M., Murad F., Scheller R. H., Tsien R. W. Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc. natl Acad. Sci. USA. 91:1994;2151-2155.
151. A, binding in the brains of aged rats and monkeys. Neurobiol. Aging. 12:1991;93-98.
152. Whiteaker P., Garcha H. S., Wonnacott S., Stolerman I. P. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats. Br. J. Pharmac. 116:1995;2097-2105.
153. Whitehouse P. J., Kalaria R. N. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis. Assoc. Disord. 9:1995;3-5.
154. Wigström H., Gustafsson B. Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition. Nature. 301:1983;603-604.
155. Wilkie G. I., Hutson P., Sullivan J. P., Wonnacott S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 21:1996;1141-1148.
156. Wilson A. L., Langley L. K., Monley J., Bauer T., Rottunda S., McFalls E., Kovera C., McCarten J. R. Nicotine patches in Alzheimer's disease: pilot study on learning, memory and safety. Pharmac. Biochem. Behav. 51:1995;509-514.
157. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1992;1040-1062.
158. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
159. Wood P. L. Pharmacology of the second messenger, cyclic guanosine 3′,5′-monophosphate, in the cerebellum. Pharmac. Rev. 43:1991;1-25.
160. Wood P. L., Richard J. W., Pilapil C., Nair N. P. V. Antagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellum. Neuropharmacology. 21:1982;1235-1238.
161. Wood P. L., Emmett M. R., Rao T. S., Cler J., Mick S., Iyengar S. Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quisqualate-, kainate-, harmaline-, and pentylenetetrazole-dependent increases in cerebellar cyclic GMP in vivo. J. Neurochem. 55:1990;346-348.
162. Wynick D., Smith D. M., Ghatei M., Akinsanya K., Bhogal R., Purkiss P., Byfield P., Yanaihara N., Bloom S. R. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc. natl Acad. Sci. USA. 90:1993;4231-4235.
163. Yamada K. A., Tang C. M. Benzothiadiazines inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J. Neurosci. 13:1993;3904-3915.
164. Zarrindast M. R., Sadegh M., Shafaghi B. Effects of nicotine on memory retrieval in mice. Eur. J. Pharmac. 295:1996;1-6.
165. Zhuo M., Hu Y., Schultz C., Kandel E. R., Hawkins R. D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639.
166. Zhuo M., Kandel E. R., Hawkins R. D. Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus. NeuroReport. 5:1994;1033-1036.
167. Zini S., Roisin M. P., Langel U., Bartfai T., Ben-Ari Y. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur. J. Pharmac. 245:1993;1-7.
168. Zwiller J., Ghandour M. S., Revel M. O., Basset P. Immunohistochemical localization of guanylate cyclase in rat cerebellum. Neurosci. Lett. 23:1981;31-36.